SURI ETF

$15.85
Screen 3,400+ ETFsFind similar ETFs with lower fees
Showing top 20 of 36 holdings— Unlock all holdings(as of Dec 31, 2025)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgSectorIndustry
1PAGPPlains Gp Holdings Lp32.17%1,272,360$24.95M••••••••••••••••••••••
2-Cash11.32%8,781,461$8.78M••••••••••••••••••••••
3ACHVAchieve Life Sciences Inc8.35%1,184,512$6.48M••••••••••••••••••••••
4PHATPhathom Pharmaceuticals Inc6.47%321,935$5.02M••••••••••••••••••••••
5MISTMilestone Pharmaceuticals Inc4.25%1,506,405$3.30M••••••••••••••••••••••
6VRDNViridian Therapeutics Inc4.05%103,531$3.14M••••••••••••••••••••••
7DCTHDelcath Systems Inc3.44%261,126$2.67M••••••••••••••••••••••
8ABEOAbeona Therapeutics Inc Common Stock Usd.013.28%500,342$2.55M••••••••••••••••••••••
9-Achieve Life Sciences I Wts 30Jun303.08%966,667$2.39M••••••••••••••••••••••
10CLDXCelldex Therapeutics Inc3.00%85,000$2.32M••••••••••••••••••••••
11CMPSCompass Pathways Plc Adr2.85%290,000$2.21M••••••••••••••••••••••
12OCS:SMOculis Holding Ag2.81%98,765$2.18M••••••••••••••••••••••
13IVA:PAInventiva Sa Unspon ADR2.14%337,662$1.66M••••••••••••••••••••••
14KYTXKyverna Therapeutics Inc2.10%192,339$1.63M••••••••••••••••••••••
15-Wts - Milestone Pharmaceuticals Inc Series A1.64%1,842,974$1.27M••••••••••••••••••••••
16NKTRNektar Therapeutics Class A1.50%28,000$1.16M••••••••••••••••••••••
17ATHAAthira Pharma, Inc Prvhld1.38%149,279$1.07M••••••••••••••••••••••
18SABSSab Biotherapeutics, Inc.1.04%208,227$803.8K••••••••••••••••••••••
19TELSAT 5.625 12/06/2Telesat Canada/Telesat L 5.625 12/06/20261.04%1,000,000$810.2K••••••••••••••••••••••
20-Wts - Milestone Pharmaceuticals Inc Series B0.75%1,842,974$580.5K••••••••••••••••••••••
16+ more holdings available
See all 36 holdings with sector, industry, share changes & CSV export
Unlock All Holdings — $149 $60/mo
Limited to first 500 subscribers - Cancel anytime

SURI ETF All Holdings

SURI holdings total 36 positions. The top 10 holdings account for 79.4% of the fund, led by Plains Gp Holdings Lp at 32.2%, Cash at 11.3%, Achieve Life Sciences Inc at 8.3%.

SURI portfolio concentration is relatively high, with the top 10 representing 79.4% of total assets. The largest sector exposure is Health Care at 42.0%.

SURI sector allocation provides a detailed breakdown. SURI overlap tool shows how holdings compare to other funds in your portfolio.

SURI ETF Holdings

36 of 36 holdings

  • 1

    Plains Gp Holdings Lp

    PAGPEnergy
    32.17%
  • 2

    Cash

    Other
    11.32%
  • 3

    Achieve Life Sciences Inc

    ACHVHealth Care
    8.35%
  • 4

    Phathom Pharmaceuticals Inc

    PHATHealth Care
    6.47%
  • 5

    Milestone Pharmaceuticals Inc

    MISTHealth Care
    4.25%
  • 6

    Viridian Therapeutics Inc

    VRDNHealth Care
    4.05%
  • 7

    Delcath Systems Inc

    DCTHHealth Care
    3.44%
  • 8

    Abeona Therapeutics Inc Common Stock Usd.01

    ABEOHealth Care
    3.28%
  • 9

    Achieve Life Sciences I Wts 30Jun30

    Other
    3.08%
  • 10

    Celldex Therapeutics Inc

    CLDXHealth Care
    3.00%
  • 11

    Compass Pathways Plc Adr

    CMPSHealth Care
    2.85%
  • 12

    Oculis Holding Ag

    OCS:SMUnknown
    2.81%
  • 13

    Inventiva Sa Unspon ADR

    IVA:PAUnknown
    2.14%
  • 14

    Kyverna Therapeutics Inc

    KYTXHealth Care
    2.10%
  • 15

    Wts - Milestone Pharmaceuticals Inc Series A

    Other
    1.64%
  • 16

    Nektar Therapeutics Class A

    NKTRUnknown
    1.50%
  • 17

    Athira Pharma, Inc Prvhld

    ATHAHealth Care
    1.38%
  • 18

    Sab Biotherapeutics, Inc.

    SABSHealth Care
    1.04%
  • 19

    Telesat Canada/Telesat L 5.625 12/06/2026

    TELSAT 5.625 12/06/2Communication Services
    1.04%
  • 20

    Wts - Milestone Pharmaceuticals Inc Series B

    Other
    0.75%
  • 21

    Regenxbio Inc

    RGNXHealth Care
    0.73%
  • 22

    Akero Therapeutics Inc Cvr

    Other
    0.55%
  • 23

    Zevra Therapeutics Inc

    ZVRAHealth Care
    0.42%
  • 24

    Lenz Therapeutics Inc

    LENZHealth Care
    0.34%
  • 25

    Quoin Pharmaceuticals Ltd Sponsored ADR

    QNRXUnknown
    0.30%
  • 26

    Wts - Quoin Pharmaceuticals Ltd - Pre-Funded

    Other
    0.30%
  • 27

    Kalaris Therapeutics Inc

    KLRSHealth Care
    0.21%
  • 28

    Wts - Quoin Pharmaceuticals Ltd - Series H

    Other
    0.19%
  • 29

    Other Payable & Receivables

    Other
    0.14%
  • 30

    Aardvark Therapeutics Inc

    AARDHealth Care
    0.05%
  • 31

    Wts - Quoin Pharmaceuticals Ltd - Series K

    Other
    0.04%
  • 32

    Wts - Quoin Pharmaceuticals Ltd - Series J

    Other
    0.04%
  • 33

    Eiger Biopharmaceuticals Inc

    EIGRUnknown
    0.00%
  • 34

    Chinook Therapeutics, Inc

    KDNYUnknown
    0.00%
  • 35

    Wts - Tenaya Therapeutics Inc

    Other
    0.00%
  • 36

    Jasper Therapeutic Wts

    Other
    0.00%